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Development of the nervous system is finely regulated by consecutive expression of cell-specific transcription
factors. Here we show that Helios, a member of the Ikaros transcription factor family, is expressed in ectodermal
and neuroectodermal-derived tissues. During embryonic development, Helios is expressed by several brain
structures including the lateral ganglionic eminence (LGE, the striatal anlage); the cingulated, insular and
retrosplenial cortex; the hippocampus; and the accessory olfactory bulb. Moreover, Helios is also expressed by
Purkinje neurons during postnatal cerebellar development. Within the LGE, Helios expression follows a dynamic
spatio-temporal pattern starting at embryonic stages (E14.5), peaking at E18.5, and completely disappearing
during postnatal development. Helios is expressed by a small population of nestin-positive neural progenitor
cells located in the subventricular zone as well as by a larger population of immature neurons distributed
throughout the mantle zone. In the later, Helios is preferentially expressed in the matrix compartment, where it
colocalizes with Bcl11b and Foxp1, well-known markers of striatal projection neurons. In addition, we observed
that Helios expression is not detected in Dlx1/2 and Gsx2 null mutants, while its expression is maintained in Ascl1
mutants. These findings allow us to introduce a new transcription factor in the cascade of events that take part of
striatal development postulating the existence of at least 4 different neural progenitors in the LGE. An Ascl1-
independent but Gsx2- & Dlx1/2-dependent precursor will express Helios defining a new lineage for a subset of
matrix striatal neurons.
Introduction
During embryonic development, neural lineages arederived from neural progenitor cells (NPCs) localized in
specific brain areas, which consecutively generate both neurons
and glial cells [1,2,3]. Within the developing telencephalon,
neural stem cells from the wall of the lateral ventricle, the ven-
tricular zone (VZ) [4], undergo successive divisions to expand
the pool of NPCs, thereby increasing the volume of the sub-
ventricular zone (SVZ). A number of signaling pathways con-
trolled by different factors, such as Notch, Wnt, or FGFs, have
been implicated in the self-renewal, proliferation and/or main-
tenance of the undifferentiated state of NPCs [5]. At certain de-
velopmental stages depending on the telencephalic area, NPCs
divide for the last time and become specific immature neurons
thatmigrate to postmitotic regions [4,6,7].Multiple transcription
factors finely regulate this neurogenic process [8,9].
1Department of Cell Biology, Immunology and Neuroscience, and Cell Therapy Program, Faculty of Medicine, Institut d’Investigacions
Biome`diques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
2Centro de Investigacio´n Biome´dica en Red sobre Enfermedades Neurodegenerativas, Spain.
3Nina Ireland Laboratory of Developmental Neurobiology, Department of Psychiatry, University of California at San Francisco, San
Francisco, California.
4Division of Developmental Biology, Children’s Hospital Research Foundation, Cincinnati, Ohio.
5Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts.
6Alicante Neuroscience Institute, Miguel Hernandez University, Consejo Superior de Investigaciones Cientı´ficas (CSIC), San Juan de
Alicante, Spain.
7Departamento de Neurobiologı´a Molecular, Celular y del Desarrollo, Instituto Cajal, Consejo Superior de Investigaciones Cientı´ficas
(CSIC), Madrid, Spain.
8Department of Cancer Biology, Institut de Ge´ne´tique et de Biologie Mole´culaire et Cellulaire, Institut national de la sante´ et de la recherche
me´dicale (INSERM), Centre National de la Recherche Scientifique, Illkirch, France.
*These authors contributed equally to this work.
**Present affiliation: Department of Molecular Neurobiology, National Institute for Medical Research, The Ridgeway, Mill Hill, London,
United Kingdom.
STEM CELLS AND DEVELOPMENT
Volume 21, Number 12, 2012
 Mary Ann Liebert, Inc.
DOI: 10.1089/scd.2011.0607
2239
The striatum is one of the main telencephalic constituents
of the basal ganglia; its embryonic anlage is the lateral gan-
glionic eminence (LGE) [10,11]. The progenitor zone of the
LGE is the germinal zone (GZ) a source of striatal projection
neurons and olfactory bulb interneurons [10,12,13]. Within
the LGE, separate waves of neurogenesis are coupled to the
production of different compartments known as the patches,
or striosomes, and the matrix [14]. Neurogenesis between
E12 and E13 produces clusters of substance P (SP)-expressing
neurons that form the patches or striosomal compartment.
The second wave of neurogenesis taking place at E14–E16 in
mice will give rise to the matrix compartment, which con-
tains both enkephalin (ENK)- and SP-positive neurons
[15,16].
Several transcription factors such as Gsx1 & 2 (formerly
named Gsh1 & 2), Ascl1 (formerly named Mash1) and Dlx-
family members have distinct but overlapping patterns of
expression in the VZ, SVZ, and mantle zone (MZ), and
regulate distinct steps in LGE patterning and/or differenti-
ation [17,18,19,20]. In addition to these transcription factors,
Ebf-1, Bcl11b (formerly named Ctip2) and Ikaros are exclu-
sively expressed in the striatal MZ where they regulate dif-
ferentiation of striatal projection neurons [21,22,23,24].
Ikaros-family members are a Kru¨ppel-type zing-finger
transcription factors that play essential roles during lym-
phocyte development [25,26]. Ikaros is the founder member
of this small family of DNA-binding proteins which consists
of Ikaros, Helios, Aiolos, Eos, and Pegasus [27,28]. Besides the
well characterized role of this family of transcription factors
during hematopoietic development, Ikaros has also been re-
cently involved in LGE development [24,29]. However, little
is known about the expression of Helios in the central ner-
vous system (CNS). In this work on the developing mouse,
we present the first description of Helios expression during
brain development. We focused on its transient expression in
the developing striatum, providing evidence that Helios is a
marker of a subpopulation of immature matrix striatal neu-
rons. Further, we defined Helios’ expression in several tran-
scription factor mutants, thereby placing it within the known
transcriptional hierarchy that drives striatal development.
Material and Methods
Animal Subjects
Mice were maintained in standard conditions with food
and water ad libitum. All animal procedures were approved
by local committees [Universitat de Barcelona, CEEA (133/
10) and Generalitat de Catalunya (DAAM 5712)], in accor-
dance with the European Communities Council Directive
(86/609/EU). B6CBA wild-type (wt) mice (from Charles
River Laboratories, Les Oncins, France), Dlx-5/6-Cre-IRES-
EGFP transgenic mice [12], and Ikaros [30], Gsx2 [31], Ascl1
[32], Dlx-1/2 [33], Helios [34], and Ebf-1 [35] knockout mice
(–/–) were used. E18.5 Dlx5/6-cre-IRES-EGFP/gtROSA double
transgenic brains were obtained by crossing heterozygous
B6;129-Gtrosa26tm1Sho(gtROSA) mice [36] with hemizygous
Dlx5/6-cre-IRES-EGFP mice.
All strains were maintained by backcrossing to C57BL/6
mice. Genotypes were determined by polymerase chain re-
action (PCR) as described elsewhere [12,30,31,32,33,34,35].
The day of pregnancy, determined by the first detection of a
vaginal sperm plug in daily inspection, was considered
embryonic day (E)0.5.
Histology
All immunostainings were performed with the following
antibodies: anti-Helios (1:1,000; polyclonal; a generous gift
of Dr. Stephen T. Smale (University of California Los An-
geles (UCLA) School of Medicine [37]), anti-Helios (1:50;
polyclonal, Santa Cruz), anti-Ikaros (1:2,000; monoclonal;
[24]), anti-nestin (Rat 401; 1:50; polyclonal; Developmental
Studies Hybridoma Bank; The University of Iowa), anti-
GFAP (1:200; monoclonal; Sigma Chemical Co.), anti-b-III-
tubulin (Tuj1; 1:200; monoclonal; Sigma Chemical Co.),
anti-MAP2 (1:200; monoclonal; Sternberger Monoclonals),
anti-NeuN (1:100; monoclonal; Millipore), anti-dopamine-
and cAMP-regulated phosphoprotein of 32 kDa (DARPP-32;
1:500; polyclonal; Chemicon International, Inc.), anti-Ctip2
(1:200; polyclonal; Abcam), anti-calbindin (1:1000; mono-
clonal; Sigma Chemical Co.) and anti-Foxp-1 (1:200; poly-
clonal; Abcam).
For histological preparations, brains were removed at
specific developmental stages and frozen in dry-ice cooled
isopentane. Serial coronal cryostat sections (14mm) were cut
on a cryostat and collected on silane-coated slides and frozen
at - 20C. Fluorescent immunolabeling was performed
according to the protocol described in [38]. Briefly, tissue
sections were blocked for 1 h in PBS containing 0.3% Triton
X-100 and 1% bovine serum albumin (BSA) to avoid un-
specific binding. Thereafter, they were incubated overnight
at 4C in PBS containing 0.3% Triton X-100 and 1% BSA with
the corresponding primary antibodies. After three PBS wa-
shes, sections were incubated for 2 h at room temperature
with the following secondary antibodies: Cy3-conjugated
donkey anti-rabbit IgG (1:500) or Cy2-conjugated donkey anti-
mouse or Cy3 donkey anti goat (1:200; all from Jackson Im-
munoresearch Laboratories Inc.). At the end, tissue sections
were counterstained with 4,6’-diamidino-2-phenylindole
(DAPI; Sigma Chemical Co.) and mounted in Mowiol (Cal-
biochem). Fluorescent photomicrographs were taken on a
Leica TCS SL laser scanning confocal spectral microscope
(Leica Microsystems Heidelberg GmbH). All pictures acqui-
sitions were done as tiff files and adjustments of brightness
and contrast were done with Adobe Photoshop 6.0 program
(Adobe Systems Incorporated). No signal was detected in
control preparations from which the primary antibody was
omitted.
Nonisotopic in situ hybridization was performed using a
riboprobe for Helios gene (Gene accession No. NM_011770).
To obtain the riboprobe, an EcoRI digested fragment of
the MSCV plasmid encoding Helios (kindly provided by
Dr. Christopher A. Klug, University of Alabama at Bir-
mingham [39]) was cloned into Bluescript SK II vector
(Stratagene). To obtain the antisense probe, the plasmid
was linearized with SacI, and transcribed with T7 RNA
polymerase using the Digoxigenin labeling kit (Roche).
Digoxigenin labeled sense probe, linearized with KpnI and
transcribed with T3 RNA polymerase, was used as a con-
trol. In brief, brains were removed at E18.5 and frozen in
dry-ice cooled isopentane. Serial coronal cryostate sections
(14 mm) were cut on a cryostat, collected on silane-coated
slides, and frozen at - 20C. Frozen tissue sections were air
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dried, fixed in 4% paraformaldehyde in PBS for 20min at
4C, and processed for in situ hybridization as described
elsewhere [40].
Production of viral particles and cell transduction
To overexpress Helios, we used the pLV-Helios-IRES-EGFP
plasmid or the pLV-IRES-eGFP plasmid, which encode for
human Helios and the green fluorescent protein (eGFP) or for
eGFP alone, respectively. The pLV-IRES eGFP plasmid was
generated as described elsewhere [41]. Briefly, MCS-IRES-
eGFP was cloned from the PRV-IRES-eGFP (Genetrix SL,
Tres Cantos) using the BamHI and the SalI restriction sites
into the pRRLsinPPT plasmid (pRRL) constructed by the
Miami Project to Cure Paralysis Viral Vector Core Lab based
on the lentiviral transducing plasmid developed by Naldini
et al. [42]. To construct the pLV-Helios-IRES-eGFP, the hu-
man Helios gene from the SPORT6-Helios plasmid (Invitrogen
S.A.) was cloned into pLV-IRES-eGFP between BamHI and
XhoI sites.
To overexpress Gsx2, the human Gsx2 gene from the
pcDNA-hGsx2 plasmid kindly provided by Dr. Peter Mar-
ynen (Universite´ de Leuven, Belgium) was PCR-cloned into
the retroviral vector pRV-IRES-eGFP using the MCS BamHI
and XhoI sites as described elsewhere [41].
For retroviral or lentiviral production, 293T cells were
plated at a density of approximately 6· 104 cells per cm2. The
following day, cells were transfected by either a 3-plasmid
system (pRV-Gsx2-IRES-eGFP or pRV-IRES-eGFP plasmid,
the plasmid that expresses gag and pol genes, and the plasmid
that expresses vesicular stomatitis virus G) or a 4-plasmid
system (pLV-IRES-eGFP or pLV-Helios-IRES-eGFP plasmid,
the plasmid that expresses HIV-1 Rev, the plasmid that ex-
presses gag and pol genes, and the plasmid that expresses
vesicular stomatitis virus G) using the calcium phosphate/
DNA coprecipitation method. Cells were transfected for 7 h
and afterwards the mediumwas replaced with fresh one. The
supernatant from vector-producing 293T cells was collected
every 22 h during 3 days. Then, the supernatant was passed
through a 0.45-mm-pore-size filter to remove producer cells
and subjected to 2 centrifugations at 4C and 25000 g for
120min to concentrate the virus. The virus-containing pellet
was dissolved in BSA 1%. To determine the viral titer, a total
of 2· 105 3T3 or 293T cells were inoculated with serial dilu-
tions of concentrated retrovirus or lentivirus. Forty-eight
hours after infection, eGFP titers (IU/mL) were determined
by using a fluorescence-activated cell scanner (FACS).
Neurosphere assay and overexpression
LGE from E14.5 wt mice were dissected out and me-
chanically disaggregated as previously described [24].
Briefly, LGE-derived neurosphere cultures were obtained by
seeding 50,000 cells/cm2 in basal medium [Dubelcco’s
modified Eagle’s medium (DMEM; Sigma Chemical Co.):F12
(Invitrogen S.A.) (1:1), 0.3% glucose (Sigma Chemical Co.),
0.3mg/mL glutamine (Invitrogen S.A.), 5mM HEPES (In-
vitrogen S.A.), 100 IU/mL penicillin, 100mg/mL strepto-
mycin (Invitrogen S.A.), 4mg/mL heparin (Sigma Chemical
Co.), 4mg/mL BSA (Sigma Chemical Co.), 1·N2 supple-
ment (Invitrogen S.A.)], supplemented with 20 ng/mL fi-
broblast growth factor (Sigma Chemical Co.) and 10 ng/mL
epidermal growth factor (Invitrogen S.A.). Every 5 days,
neurospheres were collected, dissociated by pipetting ap-
proximately 40 times with a P100 micropipette, and plated
down in fresh media at a density of 10,000 cells/cm2.
To overexpress mouse Dlx-2, we used the pCAGGS-Dlx-2
vector as described previously Studhmer and colleagues [43].
To this end, neurospheres were disaggregated mechanically
and5· 106 cellswere transfectedbynucleofection following the
manufacturer’s protocol (A33 Nucleofector Program; Amaxa
Biosystems). Viable cells were counted by trypan blue exclu-
sion and plated down at a cell density of 50,000 cells/mm2.
To overexpress Helios or Gsx2, neurospheres were trans-
duced with the pLV-Helios-IRES-eGFP or the pRV-Gsx2-
IRES-eGFP lentivirus, or the control pLV-IRES-eGFP as
described elsewhere [41].
Cell pellets were collected 3 or 5 days after transfection or
transduction and frozen at - 80C for mRNA analysis.
Q-PCR assay
Gene expression was evaluated by quantitative PCR (Q-
PCR) assays as previously described by Martin-Ibanez and
coworkers [44]. The following TaqMan Gene expression
assays (Applied Biosystems) were used: 18s, Hs99999901_s1;
Helios, Mm00496108_m1; vimentin, Mm00449208_m1; nestin,
Mm00450205_m1; b-tubulin III, Mm00727586_s1; GFAP,
Mm00546086_m1; olig1, Mm00497537_s1; olig2, Mm01210556_
m1; Dlx2, Mm00438427_m1; and Gsx2, Mm446650_m1. To
provide negative controls and exclude contamination by
genomic DNA, the reverse transcriptase was omitted in the
cDNA synthesis step, and the samples were subjected to the
PCR reaction with each TaqMan gene expression assay.
Analysis and quantification was performed with the
Comparative Quantitation Analysis program of the MxPro
Q-PCR analysis software version 3.0 (Stratagene), using the
18S gene expression as internal loading control. All Q-PCR
assays were performed in duplicate and repeated for at least
three independent experiments. The results were expressed
as relative levels with respect to the expression of the same
gene in E14.5 for developmental studies or the control vector
overexpressing cells considered as 100%.
Statistical analysis
All results are expressed as the mean of independent ex-
periments – standard error of the mean. Results were ana-
lyzed using the Student’s t-test or one-way analysis of
variance, followed by the Bonferroni post-hoc test.
Results
Helios is expressed in specific brain and sensitive
areas during mouse development
To study the expression and distribution of Helios during
mouse brain development, we performed immunohisto-
chemistry analysis at different developmental stages. At
E16.5, Helios was expressed in the granule cell layer of the
accessory olfactory bulb (Fig. 1A), the LGE, the cingulated
(Fig. 1B), insular (Fig. 1B), and retrosplenial (Fig. 1C) cortices,
and hippocampal CA1/2 (Fig. 1C). At early postnatal ages,
Helios expression was also observed in the Purkinje cell layer
of the cerebellum (Fig. 1D), while its expression decreased in
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the above-mentioned brain areas. In the adult brain, Helios
expression was not detected (data not shown).
Helios is also expressed outside of the CNS during
development (Supplementary Fig. S1; Supplementary ma-
terials are available online at http://www.liebertpub
.com/). At E16.5, Helios expression was detected in the nasal
and oral cavities as well as in the optic vesicles. Within the
nasal cavity, this zinc finger transcription factor was de-
tected in the epithelial tissue (Supplementary Fig. S1A). Si-
milarly, in the oral cavity, Helios was also detected in the
epithelium of the palate (Supplementary Fig. S1B). Both
epithelia showed Helios expression located in the interme-
diate layers but not in basal cells, which constitute the stem
cells of the epithelium. In addition, Helios was also detected
in the taste buds of the tongue (Supplementary Fig. S1B).
Within the optic vesicles, this transcription factor was de-
tected in the neuro-epithelial layers such as the pigmented
epithelium and the neuronal layer of the retina (Supple-
mentary Fig. S1C).
Helios shows a dynamic expression pattern
during LGE development
Here we focused our study on Helios expression in the
LGE and its derivative the striatum, because of the role of
other Ikaros-family members in striatal development [29,24].
Immunohistochemistry studies performed at different LGE
developmental stages showed that Helios expression was
initially detected at E14.5; its levels increased at later stages,
peaking between E18.5 and P3 (Fig. 2A). Subsequently, the
FIG. 1. Helios is expressed in specific brain areas during central nervous system development. Helios immunohistochemistry
was performed in mouse brain coronal sections at E16.5 and P15. Representative fluorescent photomicrographs corre-
sponding to anterior and posterior sections at E16.5 show Helios expression in: (A) the granular layer of accessory olfactory
bulb from the anterior (A1, A2; note that A2 is a high magnification of A1) to the posterior axis (A3, A4; A4 represents the
inset in A3); (B) the lateral ganglionic eminence (LGE), the cingulate (Cing) and insular (Ins) cortex; and (C) the retrosplenial
cortex (Rs) and CA1/2 layer (CA1/2) of the hippocampus (C1, C2; C2 represents the inset in C1). (D) Helios is expressed by
Purkinje neurons in the cerebellum at P15 (D1; D2 represents the inset in D1). Scale bars: (A) 1 mm; and (C, D) 2mm.
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levels of expression decreased; after P15 expression was not
detectable (Fig. 2A). These results were confirmed by Q-PCR
(Fig. 2B). We did not detect Helios expression in the medial
ganglionic eminence, the source of striatal interneurons
(Supplementary Fig. S2).
The spatial distribution of Helios expression in the LGE
and striatum showed 2 interesting findings. First, the pattern
of Helios expression in the striatum changed over time,
starting at E14.5 in the ventrolateral area and moving to the
dorsomedial region at later stages (Fig. 2A). Secondly, we
observed that this transcription factor was detected in 2
different cell populations. During embryonic development,
Helios was expressed by a small population of cells in the
SVZ (Fig. 3A and B). Within this germinal area, Helios colo-
calized with nestin-positive NPCs (Fig 3C). In addition, He-
lios was expressed by a larger population of cells located in
the MZ at both embryonic and postnatal stages. However, in
this area Helios-expressing cells were nestin-negative but
MAP2-positive differentiating neurons.
The striatum is compartmentalized into separate matrix
and striosomal (or patch) domains, which can be defined by
specific markers [45]. The striosomal compartment is positive
for DARPP-32 at late embryonic and early postnatal stages.
During this period, Helios expressing cells appeared to be
DARPP-32-negative (Fig. 4A). This finding is in agreement
with the lack of colocalization observed at P3 between Helios
and NeuN, showing the later a patchy distribution as well
(Fig. 4B). These results suggested that Helios is expressed by
FIG. 2. Helios presents a dynamic
spatio-temporal pattern of expression
during LGE and striatal development.
(A) Helios immunohistochemistry was
performed in LGE coronal sections at
different stages of embryonic (E14.5,
E16.5, and E18.5) and postnatal (P3,
P7, and P15) development. Helios is
initially expressed at the ventro-lateral
area of E14.5 mantle zone (MZ LGE
and progressively spreads to the dor-
somedial area during development.
The expression of Helios is reduced at
later postnatal stages and only a few
positive cells can be observed at P15.
(B) Quantification of Helios mRNA
levels by Q-PCR during LGE devel-
opment showing a peak of expression
at E18.5. Results are expressed as the
mean of 3 to 5 LGE samples and error
bars represents the standard error of
the mean (SEM). Statistical analysis
was calculated by Student’s t-test;
*P < 0.05; **P < 0.005 relative to E14.5
expression. Scale bars: (A) 500mm.
(n.d., not detected).
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matrix cells. This assumption was confirmed by the colocali-
zation of Helios with Bcl11b (Fig. 4D) and Foxp1 (Fig. 4E), 2
transcription factors mainly expressed by matrix cells [22,46].
Interestingly, we did observe double staining for Helios and
NeuN at P7, a developmental stage at which the mature
neuronal marker NeuN is spread all over the LGE (Fig. 4C).
However, the cells that express high levels of Helios still lack
NeuN expression, while lowHelios-expressing cells are double
positive for both markers (Fig. 4C). This dynamic expression
of NeuN indicated a progressive maturation of striatal neu-
rons that is in agreement with previous papers demonstrating
the early maturation of neurons located in the patches [14].
FIG. 3. Helios is expressed
by nestin-positive cells in the
SVZ and MAP2-positive cells
in the MZ of the LGE. Double
immunohistochemistry was
performed in mouse brain
coronal sections at E16.5 for
Helios and b-III-tubulin (Tuj-
1) (A), MAP2 (B), and nestin
(C). (A, B). Note the expres-
sion of Helios in 2 different
cell populations: a small one
located in the Tuj-1- and
MAP2-negative SVZ of the
LGE that is spread through
the ventral and dorsal part
(A–B), and a larger one dis-
tributed along the MZ where
it colocalizes with the neuro-




tochemistry for nestin and
Helios both at the SVZ and
MZ. Colocalization of both
markers is observed in the
SVZ of the LGE. Z-analysis
shows the colocalization of
Helios positive nuclei (arrows)
surrounded by nestin-
positive intermediate filaments.
VZ, ventricular zone; SVZ,
subventricular zone; MZ,
mantle zone (delimited by
dotted area). Scale bars: (B)
150 mm; (C) 100 mm.
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FIG. 4. Helios is expressed by neuronal precursors located in the striatal matrix compartment. Double immunohisto-
chemistry was performed in mouse brain coronal sections at several embryonic and postnatal stages for Helios and striatal
neuronal markers such as: DARPP-32 (A), NeuN (B, C), Bcl11b (Ctip2) (D), and Foxp1 (E). Representative photomicrographs
show that Helios is not expressed in the striosomal compartment, since it has a complementary distribution with DARPP-32, a
striosomal marker at this stage (A1, A2; note that A2 is a high magnification of A1). At P3, Helios does not colocalize with
NeuN, a marker of mature neurons that at this stage presents a striosomal distribution (B1, B2; note that B2 is a high
magnification of B1). However, both markers are coincident in some cells at P7, developmental stage at which NeuN is
staining most of the striatal neurons (C1, C2; note that C2 is a high magnification of C1). High magnification picture shows
that the cells that express high levels of Helios are negative or express low levels of NeuN (open arrows), while low Helios-
expressing cells are positive for both markers (closed arrows) (C1). In addition, Helios is expressed by Bcl11b (Ctip2) (D) and
Foxp1-positive neurons (E), two markers of striatal projection neurons. Scale bars: (A1, B1) 500 mm; (A2, B2, C, D, E) 100mm.
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FIG. 5. Helios is expressed by a specific neuronal precursor downstream of Gsx2 and Dlx1/2 during LGE development.
Immunohistochemistry and in situ hybridization analysis of Helios expression was performed in several knockout animals for
transcription factors involved in striatal projection neurons development. Gsx2 knock-out mice (Gsx2EGFP/EGFP) show a
complete lack of Helios expression (A). In contrast, normal Helios protein expression was detected in Ascl1–/– mice (B). In situ
hybridization analysis for Helios mRNA in wt and Dlx-1/2–/– mice show that the expression of this transcription factor is lost
in the LGE but conserved in cortical areas at E18.5 (C). Double immunohistochemistry for Helios and eGFP performed in
recombined Dlx-5/6-Cre-IRES-GFP/gtROSA (Dlx5/6-GFP) mice shows that Helios does not colocalize with eGFP positive cells
at E18.5 (D). In addition, Helios immunohistochemistry performed in wt and Ebf-1–/– mice at E18.5, shows that its expression
is detected in Ebf-1–/– mice although its distribution changes due to the LGE alterations described in these mice (E). Similarly,
Helios protein expression is also preserved in Ikaros–/– mice (IK–/–) at E18.5 (F). Over-expression of Gsx2 (G) or Dlx2 (H) in
neurosphere cultures does not affect Helios expression levels 3 days after transduction or transfection, suggesting that this
transcription factor is not directly regulated by Gsx2 or Dlx2. Results are expressed as the mean of 4 to 5 neurosphere cultures
and error bars represent the s.e.m. Statistical analysis was calculated by Student’s t-test; ***p < 0.001 relative to neurospheres
transduced or transfected with the respective control vectors. Scale bars: (A, B) 500mm; (D) 150 mm; (E) and (F) 500mm.
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Helios is expressed by a specific type
of neuronal precursor in the LGE
The germinal zone of the LGE is the main source of striatal
projection neurons. In order to study the relationship between
Helios and other transcription factors involved in the devel-
opment of these neurons we analyzed the expression of this
transcription factor in knockout mice for Gsx2, Ascl1, Dlx-1/2,
Ebf1, and Ikaros (Fig. 5). Our results showed that Helios-
positive cells completely disappeared in Gsx2 knockout mice
(Fig. 5A). However, Helios was normally expressed in Ascl1–/–
mice (Fig. 5B). On the other hand, Dlx-1/2–/– mice lacked de-
tectable Helios expression in the LGE, although its expression
was not affected in the cerebral cortex (Fig. 5C). These findings
indicated that Helios is expressed downstream of Gsx2 and
Dlx1/2 specifically in the LGE. However, we demonstrated
that Helios is not directly regulated by Gsx2 or Dlx2 since
overexpression of these transcription factors in neurosphere
cultures did not modify Helios expression (Fig. 5G and H).
Helios expression levels appeared unchanged in Ebf-1–/–
(Fig. 5E) and Ikaros–/– mice (Fig. 5F), although there was a
change in the distribution of Helios-expressing cells in both
mutants (Fig. 5E and F), probably reflecting striatal pheno-
types that have been previously described [24,47].
Interestingly, the analysis of Helios expression in recom-
binant Dlx-5/6-Cre-IRES-GFP/gtROSA transgenic mice
showed a lack of colocalization with GFP-positive cells
(Fig. 5D). Thus, Helios-positive cells appear to be in distinct
immature striatal neurons, or alternatively, that it could be
expressed upstream of Dlx-5/6.
Dimerization could be a prerequisite for DNA binding and
function of all Ikaros-family members. Like Aiolos and Ikaros,
Helios can dimerize with itself as well as with other family
members [48]. To further analyze the relation between Ikaros-
family members within the LGE, double immunohisto-
chemistry for Helios and Ikaros was performed at E18.5. A
lack of coincidence between these 2 transcription factors is
shown in Fig. 6A. The same result was obtained at E14.5 and
E16.5 (data not shown). In addition, the expression of Ikaros
was not affected in Helios knockout mice (Fig. 6B), indicating
a parallel or independent expression of these two transcrip-
tion factors in different neuronal precursors.
Helios induces the expression of the neuronal
marker b-III-tubulin in neurosphere cultures
All previous results suggested that Helios might participate
in striatal development as a neurogenic factor. To test this
hypothesis, we overexpressed Helios in neurosphere cultures,
and 5 days later we tested the expression of several neural
markers including vimentin, nestin, b-III-tubulin, GFAP,Olig1,
and 2. Our results showed thatHelios overexpression increased
the levels of the neuronal marker b-III-tubulin without affect-
ing the expression of precursors or glial markers (Fig. 7).
Present findings point to the hypothesis that Helios is a
transcription factor expressed by a specific neuronal pre-
cursor in the LGE during striatal development defining a
new lineage that might contribute to the generation of a
matrix striatal neuron subpopulation (Fig. 8).
Discussion
We demonstrate for the first time that Helios is expressed
in specific ectodermal and neuroectodermal-derived tissues.
One of these areas is the LGE, the striatum anlage, where we
FIG. 6. Helios and Ikaros are not expressed in the same LGE
cells at E18.5. Double immunohistochemistry for Helios and
Ikaros performed in the LGE at E18.5 shows a lack of coin-
cidence between these two transcription factors (A). Note
that Helios is expressed in the SVZ and MZ whereas Ikaros is
only expressed in the MZ (A). Immunohistochemistry for
Ikaros in wt and Helios–/– mice (He–/–) demonstrate no
changes in Ikaros expression in the absence of Helios (B). Scale
bars: (A) 400mm; (B) 500 mm.
FIG. 7. Helios over-expression increases the levels of the
neuronal marker b-III-tubulin. Over-expression of Helios in
neurosphere cultures for 5 days induces an increase in the
levels of the neuronal marker b-III-tubulin (Tuj-1). However,
the expression of markers for neural precursors, vimentin
and nestin, or glial cells, GFAP and Olig 1 and 2, are not
modified after Helios over-expression in the neurosphere
culture. Results are expressed as the mean of 5 neurosphere
cultures and error bars represent the s.e.m. Statistical anal-
ysis was calculated by Student’s t-test; **p < 0.005 relative to
neurospheres transduced with the control vector.
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observed that this transcription factor is expressed by both
NPCs as well as by a subset of striatal immature neurons.
The relationship between Helios and other transcription
factors involved in striatal development allowed us to define
a new lineage that could determine the specific development
of a subpopulation of matrix striatal projection neurons.
Helios is expressed by a specific precursor
of striatal projection neurons during
LGE development
Helios was originally described as a cell-type specific he-
matopoietic factor that is involved in the development of
lymphocytes [37]. However, here we show that this tran-
scription factor is expressed in several regions of the CNS
and peripheral nervous system (PNS).
In the present work we focused on the characterization of
Helios expression in the LGE, the progenitor region for the
striatum. It is initially expressed in the ventro-lateral area of
the LGE MZ at E14.5. This initial detection spatially coincides
with the early pattern of expression of the mature markers of
striatal projection neurons, such as proenkephalin [49]. In
addition, as embryonic striatal development occurs, Helios-
expressing cells appear dorsomedially following the same
dynamics that has been previously described for proenke-
phalin [49]. These results suggest that Helios might be in-
volved in the determination of a neuronal precursor toward
a striatal projection neuron that would be committed to an
enkephalinergic phenotype. Keeping with this view, we ob-
serve that all Helios-expressing cells are positive for Bcl11b,
an important transcription factor for striatal projection neu-
rons development that is detected in NPCs at E13.5 [22].
Interestingly, Helios expression also colocalizes with the
Forkhead transcription factor Foxp1. Several Foxp-family
genes have been detected during telencephalon development
[46,50,51]. Although all Foxp examined genes are expressed
in the developing LGE, Foxp1 shows a preferential expression
for a subset of striatal projection neurons located in the
matrix compartment [46] while Foxp2 and Foxp4 are more
coincident with markers of the striosomal compartment.
Therefore, these findings indicate that Helios and Foxp1 are
both expressed by a common neuronal precursor that will be
differentiated into a matrix striatal projection neuron. Keep-
ing with this view, Helios does not colocalize with DARPP32,
a well known striosomal marker [52,53]. The colocalization of
Foxp1 and Helios is not restricted to the LGE; they are also
coexpressed in the cortical plate and the CA1/2 subfield of
the hippocampus (present results and references 46 and 51]).
Therefore, Helios and Foxp1 may share functions in regulating
the development of the striatum, cortex, and hippocampus.
Helios is expressed in the dLGE and the vLGE
Similarly to Foxp1, Helios is also detected in a subset of
cells localized in the SVZ where it coincides with the NPC
marker nestin. In this area, Helios is expressed in both the
dorsal (dLGE) and the ventral LGE (vLGE).
The dLGE and vLGE are sources for both striatal projection
neurons and olfactory bulb interneurons [12,54,55,56,57, 58].
While Helios was expressed in differentiating striatal neurons,
we did not detect Helios-expressing cells migrating to the ol-
factory bulb, or in interneurons of the main olfactory bulb,
during development or in adulthood. On the other hand, we
did detect Helios expression in cells of the accessory olfactory
bulb, which is responsible for the detection of pheromones
[59,60,61]. It has recently been reported that Bcl11b is also ex-
pressed in the accessory olfactory bulb [62], where this tran-
scription factor plays an important role during its development
[63]. Interestingly, the expression of Helios is also coincident
with the expression of Bcl11b in the respiratory epithelium of
the nasal cavity (present results and reference 62).
Helios defines a new lineage of neuronal progenitors
during LGE development
The expression of Helios in the LGE suggests that it par-
ticipates as a neurogenic factor for the development of a
subset of striatal projection neurons. In fact, we demonstrate
that Helios overexpression induces an increase in the levels of
neuronal markers without altering the expression of glial
markers. Distinct transcription factors acting in cascades
underlie the sequential steps of the determination and dif-
ferentiation of the striatal projection neurons. Specification of
the striatum depends on the function of the Gsx1&2 ho-
meobox genes, which are expressed in the VZ and SVZ of the
LGE [64,65,54,66,55]. Mice lacking Gsx2 have defects in
dLGE specification [64]. Adding to the previously known
defects, here we showed that Helios expression is not de-
tectable in Gsx2 knockout mice.
There is clear evidence that Gsx2 drives the expression of
Dlx genes and Ascl1 in the LGE [64]. The Dlx homeobox gene
family is essential for the development of striatal projection
neurons [67,17]. Dlx1 & 2, whose expression are first detected
in the VZ and the SVZ, are the earliest Dlx genes expressed
FIG. 8. Proposed model for the definition of different lin-
eages contributing to the development of striatal projection
neurons. P, NPC; N, immature neuron; VZ, ventricular zone;
SVZ subventricular zone; MZ, mantle zone. Color image
available online at www.liebertpub.com/scd
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during LGE development [17]. Thereafter, SVZ NPCs ex-
pressing Dlx1 & 2 start expressing Dlx5 & 6 [17,68]; there-
after, immature striatal neurons maintain Dlx expression
[69]. Our results demonstrate that Helios is expressed
downstream of Dlx1 & 2 function but upstream or inde-
pendent of Dlx5 & 6 in the LGE.
Striatal development is not fully blocked in the Dlx1&2-/-
mutants [67], demonstrating that parallel and/or redundant
pathways continue to promote the generation and migration
of some striatal projection neurons. The analysis of gene
expression profiles in the double Dlx1/2–/– mice identified
Dlx-dependent and Dlx-independent pathways. The Dlx-in-
dependent pathway depends in part on the function of the
Ascl1 transcription factor [40]. Our present results show that
Helios is correctly expressed in Ascl1–/– mice, indicating that
this Ikaros-family member is expressed by Dlx-dependent but
Ascl1-independent progenitors.
Ascl1 and Dlx2 expression define different lineages of
subcortical progenitors [20]. Combinatorial expression of
these transcription factors, in conjunction with the expression
of proliferation and differentiation markers, provided evi-
dences for at least 3 lineages of NPCs in the germinal area
(P1, Ascl1–/Dlx2–; P2, Ascl1+/Dlx2–; and P3, Ascl+/Dlx2+)
[20]. In the model proposed in Fig. 8, we introduced a new
NPC which will be independent of Ascl1 (P4, Ascl1–/
Dlx2 + ). Our present and previous data also suggest that this
new lineage will give rise to 2 different cell progenies that
will define subsets of striatal projecting neurons (N3–4). One
of these progenies will express Dlx5/6 and thereafter become
Ikaros +neuronal precursors (N3) [24], whereas the other
neuronal precursors will become Helios + (N4). This is in
agreement with our present results demonstrating that Helios
and Ikaros are not coexpressed in striatal neurons.
Here we also show that Helios is independent of Ebf1,
another LGE specific transcription factor that regulates the
development of SP neurons. Our previous data demon-
strated that Ebf1 is independent of Ikaros [24] and its ex-
pression is preserved in the Dlx1/2–/– mice [24,40]. All these
data indicate that Ebf1 might be expressed by the P2 pro-
genitor (Ascl1 + /Dlx2–) to mediate the differentiation of SP
striatal neurons by a cell-autonomous function exerted in
NPCs as described elsewhere [20]. In fact, Ebf1 has been
closely related to the development of these striatal projection
neurons [23,21]. In contrast, Ascl1 might be indirectly in-
volved in the development of striatal neurons by a non cell-
autonomous mechanism that regulates the rate at which
adjacent NPCs mature [20]. We propose that these adjacent
NPCs could be the P4 that do not express Ascl1.
Many efforts are directed to the identification of specific
transcription factors activated temporally and spatially to
regulate cell fate determination during LGE development
[4,5,70]. Here we describe a new player in striatal develop-
ment named Helios. This zinc finger transcription factor de-
fines a new lineage of neural precursors that will become a
subset of matrix striatal projection neurons. Our results also
provide evidences that suggest that Helios might be involved
in the development of other specific brain areas.
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